|
|
Article: Human Genome Sciences and Medarex announce antibody collaboration.(Brief Article)
- Article from:
- BIOTECH Patent News
- Article date:
- July 1, 2001
CopyrightCOPYRIGHT 2001 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Human Genome Sciences, Inc. (Rockville, MD; 301-309-8504) and Medarex, Inc. (Princeton, NJ; 609-430-2880) announced that they have entered an agreement whereby the parties intend to use Medarex's technology to create fully human antibodies for commercialization by Human Genome Sciences. Under the agreement Human Genome Sciences has an option to exclusively license therapeutic and diagnostic antibody products resulting from the collaboration. Medarex is entitled to receive license fees, milestone payments and royalties on any commercial sales of products that result from the collaboration.
Medarex intends to use its Human Antibody Develop-ment System called ...
Related newspaper, magazine, and journal articles:
|
|
Article: Human Genome Sciences Receives Clinical ...
PR Newswire;
September 6, 2001 ;
700+ words
... ... Sept. 6 /PRNewswire/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ... GlaxoSmithKline investigators using Human Genome Sciences' technology. (Photo ... agreement signed in 1993, Human Genome Sciences is entitled to receive clinical ...
|
|